Advanced Accelerator Applications (AAA), is a Novartis Company focused on transforming the lives of patients through their leading innovation in nuclear medicine. AAA is dedicated to developing treatments for several leading types of cancer through the application of precision, targeted radioligand therapy. Their goal is to leverage industry leading pipelines to unlock the benefit of radioligand therapy across different tumor types and ultimately reimagine nuclear medicine.